Early growth response-1 in cardiovascular pathobiology

被引：254

作者：

Khachigian, LM ^{[1
]}

机构：

[1] Univ New S Wales, Dept Pathol, Ctr Vasc Res, Sydney, NSW 2052, Australia

[2] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia

来源：

CIRCULATION RESEARCH | 2006年 / 98卷 / 02期

关键词：

Egr-1; atherosclerosis; vascular injury; angiogenesis; ischemia and ischemia-reperfusion; allograft rejection; cardiac hypertrophy;

D O I：

10.1161/01.RES.0000200177.53882.c3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The immediate-early gene product and zinc finger transcription factor early growth response (Egr)-1 plays a key master regulatory role in multiple cardiovascular pathological processes. This article reviews the amassing recent evidence implicating Egr-1 in atherosclerosis, intimal thickening after acute vascular injury, ischemic pathology, angiogenesis, allograft rejection, and cardiac hypertrophy.

引用

页码：186 / 191

页数：6

共 86 条

[11] Inhibition of the RelA(p65) NF-κB subunit by Egr-1 [J].

Chapman, NR ;

Perkins, ND .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4719-4725

[12] Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription [J].

Cogswell, PC ;

Mayo, MW ;

Baldwin, AS .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :491-497

[13] Angiotensin II (ATII)-inducible platelet-derived growth factor A-chain gene expression is p42/44 extracellular signal-regulated kinase-1/2 and Egr-1-dependent and mediated via the ATII type 1 but not type 2 receptor - Induction by ATII antagonized by nitric oxide [J].

Day, FL ;

Rafty, LA ;

Chesterman, CN ;

Khachigian, LM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23726-23733

[14] Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression [J].

Decker, EL ;

Nehmann, N ;

Kampen, E ;

Eibel, H ;

Zipfel, PF ;

Skerka, C .

NUCLEIC ACIDS RESEARCH, 2003, 31 (03) :911-921

[15] The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells [J].

Decker, EL ;

Skerka, C ;

Zipfel, PF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26923-26930

[16] FGF-1-induced platelet-derived growth factor-A chain gene expression in endothelial cells involves transcriptional activation by early growth response factor-1 [J].

Delbridge, GJ ;

Khachigian, LM .

CIRCULATION RESEARCH, 1997, 81 (02) :282-288

[17] Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-β type II receptor [J].

Du, BH ;

Fu, CZ ;

Kent, KC ;

Bush, H ;

Schulick, AH ;

Kreiger, K ;

Collins, T ;

McCaffrey, TA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39039-39047

[18] Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth [J].

Fahmy, RG ;

Khachigian, LM .

NUCLEIC ACIDS RESEARCH, 2004, 32 (07) :2281-2285

[19] Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth [J].

Fahmy, RG ;

Dass, CR ;

Sun, LQ ;

Chesterman, CN ;

Khachigian, LM .

NATURE MEDICINE, 2003, 9 (08) :1026-1032

[20] Egr-1 target genes in human endothelial cells identified by microarray analysis [J].

Fu, MG ;

Zhu, XJ ;

Zhang, JF ;

Liang, J ;

Lin, YM ;

Zhao, LN ;

Ehrengruber, MU ;

Chen, YQE .

GENE, 2003, 315 :33-41

← 1 2 3 4 5 6 7 8 9 →